Actemra Solution For Injection 20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Actemra: Solution for injection (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TOCILIZUMAB (TOE si LIZ ue mab) is used to treat rheumatoid arthritis (RA) and certain types of arthritis in children. This medicine helps reduce joint pain and swelling. This medicine is often used with other medicines.

In-Depth Information
Select a Medication

Actemra 400mg/20ml Solution for Injection

NDC: 502420137
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Polyarticular Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis, Rheumatoid Arthritis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Store in original package until time of use
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Do not freeze
Actemra 400mg/20ml Solution for Injection

Reported Side Effects for Actemra 400mg/20ml Solution for Injection

Elevated Hepatic Enzymes Incidence:
<48.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
<19.6%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
<17.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Anaphylactoid Reactions Incidence:
0.1-0.9%*
Severity: SEVERE
Onset: RAPID
Severe Allergy Incidence:
0.1-0.9%*
Severity: SEVERE
Onset: RAPID
Antibody Formation Incidence:
0.9-1.6%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Sores Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
2.0-4.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
3.0-8.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: EARLY
Infusion-related Reactions Incidence:
4.0-20.2%*
Severity: MODERATE
Onset: RAPID
Headache Incidence:
5.0-7.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
7.1-10.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More